01—History
Accrued Liabilities History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $1.39B
2 older moves run past ±150% (largest +594.7%); point at, tap or drag across the bars to read one.
02—Ledger
03—Questions
What is accrued liabilities?
Accrued liabilities are expenses that have been incurred but not yet paid, such as wages, interest, and taxes payable.
What is Moderna, Inc.'s current accrued liabilities?
Moderna, Inc. (MRNA) annual accrued liabilities for 2025 was $1.39B, a 2.87% decline from 2024. Moderna, Inc. accrued liabilities for the quarter ending March 31, 2026 was $1.91B.
What was Moderna, Inc.'s accrued liabilities in 2024?
Moderna, Inc. annual accrued liabilities for 2024 was $1.43B, a 20.63% decline from 2023.
What was Moderna, Inc.'s accrued liabilities in 2023?
Moderna, Inc. annual accrued liabilities for 2023 was $1.80B, a 14.42% decline from 2022.
What is Moderna, Inc.'s 5-year accrued liabilities CAGR?
Moderna, Inc. accrued liabilities grew at a compound annual growth rate (CAGR) of 24.15% from FY2020 to FY2025, going from $470.0M to $1.39B over 5 years.
- Company
- Moderna, Inc.
- Ticker
- MRNA
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)